Abstract
It is well known that leukotrienes (LTs) can be divided into two classes, which differ for both the chemical structure and the pattern of biological activities: one class encompasses LTB4 only, an hydroxyacid that, mainly by means of its chemotactic action, plays a fundamental role in inflammation. The second class comprises LTC4, LTD4 and LTE4, cysteine containing leukotrienes (Cys-LTs), which can be interconverted into one another. They are potent smooth muscle constrictors, cause mucus hypersecretion in the airways and contribute to the onset of inflammation by their ability to cause plasma extravasation. Given these differences, it is not unexpected that, although both classes have been demonstrated to elicit their actions through the interaction with specific receptors, the receptors for LTB4 are totally different from those for Cys-LTs and no cross-reactivity has been shown among the two classes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Badr, K. R, Mong, S., Hoover, R. L., Schwartzberg, M., Ebert, J., Jacobson, H. R. and Harris, R. C., 1989, Leukotriene D4 binding and signal transduction in rat glomerular mesangial cells, Am. J. Physiol. 257:F280–F287.
Baud, L., Goetzl, E. J. and Koo, C. H., 1987, Stimulation by leukotriene D4 of increases in the cytosolic concentration of calcium in dimethylsulfoxide-differentiated HL-60 cells, J. Clin. Invest. 80:983–991.
Bouchelouche, P. N., Ahnfelt-Rønne, I. and Thomsen, M. K., 1990, LTD4 increases cytosolic free calcium and inositol phosphates in human neutrophils: inhibition by the novel LTD4 receptor antagonist, SR2640, and possible relation to modulation of Chemotaxis, Agents Act. 29:299–307.
Buckner, C. K., Fedyna, J. S., Robertson, J. L., Will, J. A., England, D. M., Krell, R. D. and Saban, R., 1990, An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways, J. Pharmacol. Exp. Ther. 252:77–85.
Buckner, C. K., Krell, R. D., Laravuso, R. B., Coursin, D. B., Bernstein, P. R. and Will, J. A., 1986, Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4, J. Pharmacol. Exp. Ther. 237:558–562.
Capra, V., Ragnini, D., Galbiati, E., Novarini, S., Keppler, D. and Nicosia, S., 1995, Photoaffinity labeling of Cys-leukotriene binding sites in human lung parenchyma and bronchi, Pharm. Res. 31:55.
Coleman, R. A., Eglen, R. M., Jones, R. L., Narumiya, S., Shimizu, T., Smith, W. L., Dahlén, S. E., Drazen, J. M., Gardiner, P. J., Jackson, W. T., Jones, T. R., Krell, R. D., and Nicosia, S., 1995, Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature, In Advances in Prostaglandin, Thromboxane, and Leukotriene Research edited by Samuelsson, B. et al., Raven Press, New York. Vol. 23, pp. 283–285.
Cuthbert, N. J., Tudhope, S. R., Gardiner, P. J., Abram, T. S., Norman, P., Thompson, A. M., Maxey, R. J. and Jennings, M. A., 1991a, BAY u9773-an LTC4 antagonist in the guinea pig trachea, Ann. N.Y. Acad. Sci. 629:402–404.
Cuthbert, N. J., Abram, T. S. and Gardiner, P. J., 1991b, Leukotriene receptors in sheep respiratory tissue, Ann. N.Y.Acad. Sci. 629:405–406.
Fleisch, J. H., Rinkema, L. E., Haisch, K. D., Swanson-Bean, D., Goodson, T., Ho, P. P. K. and Marshall, W. S., 1985, LY171883, l-<2-Hydroxy-3-Propyl-4-<4-(lH-tetrazol-5-yl) butoxy>Phenyl>ethanone, an orally active leukotriene D4 antagonist, J. Pharmacol. Exp. Ther. 233:148–157.
Fujiwara, H., Kurihara, N., Ohta, Hirata, K., Matsushita, H., Kanazawa, H. and Takeda, T., 1993, Effect of a new leukotriene receptor antagonist, ONO-1078, on human bronchial smooth muscle in vitro, Prostaglandins Leukot. Essent. Fatty Acids 48:241–246.
Gardiner, P. J., Abram, T. S., Tudhope, S. R., Cuthbert, N. J., Norman, P. and Brink, C., 1994, Leukotriene receptors and their selective antagonists, In Advances in Prostaglandin, Thromboxane, and Leukotriene Research edited by Dahlén, S. E. et al., Raven Press, New York. Vol. 22, pp. 49–61.
Gardiner, P. J., Norman, P., Cuthbert, N. J., Tudhope, S. R. and Abram, T. S., 1993, Characterisation of the peptido-leukotriene receptor PL2 on the ferret spleen strip, Eur. J. Pharmacol. 238:19–26.
Goldman, D. W., Gifford, L. A., Marotti, T., Koo, C. H. and Goetzl, E. J., 1987, Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4, Federation Proc. 46:200–203.
Hand, J. M., Schwalm, S. F., Auen, M. A., Kreft, A. F., Musser, J. H. and Chang, J., 1989, WY-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy) phenyl] methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pig, Prostaglandins Leukot. Essent. Fatty Acids 37:97–106.
Hay, D. W. P., Muccitelli, R. M., Tucker, S. S., Vickery-Clark, L. M., Wilson, K. A., Gleason, J. G., Hall, R. F., Wasserman, M. A. and Torphy, T. J., 1987, Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways, J. Pharmacol. Exp. Ther. 243:474–481.
Hogaboom, G. K., Mong, S., Wu, H. L. and Crooke, S. T., 1983, Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung, Biochem. Biophys. Res. Commun. 116:1136–1143.
Ishikawa, T., Kobayashi, K., Sogame, Y. and Hayashi, K., 1989, Evidence for leukotriene C4 transport mediated by an ATP-dependent glutathione S-conjugate carrier in rat heart and liver plasma membranes, FEBS Letters 259:95–98.
Ishikawa, T., Müller, M., Klünemann, C., Schaub, T. and Keppler, D., 1990, ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates, J. Biol. Chem. 265:19279–19286.
Ito, S., Hashimoto, H., Negishi, M., Suzuki, M., Koyano, H., Noyori, R. and Ichikawa, A., 1992, Identification of the prostacyclin receptor by use of [15-3H1,]19-(3-azidophenyl)-20-norisocarbacyclin, an irreversible specific photoaffinity probe, J. Biol. Chem. 267:20326–20330.
Jones, T. R., Zamboni, R., Belley, M., Champion, E., Charette, L., Ford-Hutchinson, A. W., Frenette, R., Gauthier, J. Y., Leger, S. and Masson, P., 1988, Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist, Can. J. Physiol. Pharmacol. 67:17–28.
Kenakin, T. P., Bond, R. A. and Bonner, T. I., 1992, Definition of pharmacological receptors, Pharmacol. Rev. 44:351–362.
Keppler, D., 1992, Leukotrienes: biosynthesis, transport, inactivation, and analysis, Rev. Physiol. Biochem. Pharmacol. 121:1–30.
Labat, C., Ortiz, J. L., Norel, X., Gorenne, I., Verley, J., Abram, T. S., Cuthbert, N. J., Tudhope, S. R., Norman, P., Gardiner, P. J. and Brink, C., 1992, A second cysteinyl leukotriene receptor in human lung., J. Pharmacol. Exp. Ther. 263:800–805.
Lam, B. K., Xu, K., Atkins, M. B. and Austen, K. F., 1992, Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4, Proc. Natl Acad. Sci. USA 89:11598–11602.
Lückhoff, A. and Clapham, D. E., 1992, Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca2+-permeable channel, Nature 355:356–358.
Metters, K. M., Gareau, Y., Lord, A., Rochette, C. and Sawyer, N., 1994a, Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung, J. Pharmacol. Exp.Ther. 270:399–406.
Metters, K. M., Sawyer, N. and Nicholson, D. W., 1994b, Microsomal glutathione S-transferase is the predominant leukotriene C4 binding site in cellular membranes, J. Biol. Chem. 269:12816–12823.
Metters, K. M. and Zamboni, R. J., 1993, Photoaffinity labeling of the leukotriene D4 receptor in guinea pig lung, J. Biol. Chem. 268:6487–6495.
Mong, S., Miller, J., Wu, H. L. and Crooke, S. T., 1988a, Leukotriene D4 receptor-mediated hydrolysis of phosphoinositide and mobilization of calcium in sheep tracheal smooth muscle cells, J. Pharmacol. Exp. Ther. 244:508–515.
Mong, S., Wu, H. L., Wong, A., Sarau, H. M. and Crooke, S. T., 1988b, Leukotriene D4 receptor-mediated phosphoinositol hydrolysis and calcium mobilization in rat basophilic leukemic cells, J. Pharmacol. Exp. Ther. 247:803–813.
Munson, P. J. and Rodbard, D., 1980, LIGAND: a versatile computerized approach for characterization of ligand-binding systems, Anal. Biochem. 107:220–239.
Norman, P., Abram, T. S., Cuthbert, N. J. and Gardiner, P. J., 1990, The inhibition of [3H] leukotriene D4 binding to guinea-pig lung membranes. The correlation of binding affinity with activity on the guinea-pig ileum, Eur. J. Pharmacol 182:301–312.
Norman, P., Abram, T. S., Kluender, H. C., Gardiner, P. J. and Cuthbert, N. J., 1987, The binding of [3H]leukotriene C4 to guinea-pig lung membranes. The lack of correlation of LTC4 functional activity with binding affinity, Eur. J. Pharmacol. 143:323–334.
O’Donnell, M., Crowley, H. J., Yaremko, B., O’Neill, N. and Welton, A. F., 1991, Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4, J. Pharmacol. Exp. Ther. 259:751–758.
Oliva, D., Accomazzo, M. R., Giovanazzi, S. and Nicosia, S., 1994, Correlation between leukotriene D4-induced contraction and cytosolic calcium elevation: a quantitative and simultaneous evaluation in smooth muscle, J. Pharmacol. Exp. Ther. 268:159–166.
Parekh, A. B., Terlau, H. and Stimmer, W., 1993, Depletion of InsP3 stores activates a Ca2+ and K+ current by means of a phosphatase and a diffusible messenger, Nature 364:814–818.
Piper, P. J. and Krell, R. D., 1991, Advances in the Understanding and Treatment of Asthma, Ann. N Y. Acad. Sci. 629.
Pong, S. S., DeHaven, R. N., Kuehl, F. A. J. and Egan, R. W., 1983, Leukotriene C4 binding to rat lung membranes, J. Biol. Chem. 258:9616–9619.
Pong, S. S. and DeHaven, R. N., 1983, Characterization of a leukotriene D4 receptor in guinea pig lung, Proc. Natl. Acad. Sci. USA 80:7415–7419.
Randriamampita, C. and Tsien, R. Y., 1993, Emptying of intracellular Ca2+ stores releases a novel small messenger that stimulates Ca2+ influx, Nature 364:809–814.
Rovati, G. E., Rabin, D. and Munson, P. J., 1991, Analysis, Design and Optimization of Ligand Binding Experiments. In Horizon in Endocrinology edited by M. Maggi and E. V. Geenen, Serono Symposia Publication from Raven Press, New York, Vol. 76, pp. 155–167.
Rovati, G. E., Giovanazzi, S., Mezzetti, M. and Nicosia, S., 1992, Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma, Biochem. Pharm. 44:1411–1415.
Sala, A., Civelli, M., Oliva, D., Spur, B., Crea, A. E. G., Folco, G. C. and Nicosia, S., 1990, Contractile and binding activities of structural analogues of LTC4 in the longitudinal muscle of guinea-pig ileum, Eicosanoids 3:105–110.
Salmon, J. A. and Garland, L. G., 1991, Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents, Progr. Drug Res.h 37:9–90.
Slipetz, D. M., Scoggan, K. A., Nicholson, D. W. and Metters, K. M., 1993, Photoaffinity labelling and radiation inactivation of the leukotriene B4 receptor in human myeloid cells, Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 244:161–173.
Snyder, D. W., Giles, R. E., Keith, R. A., Yee, Y. K. and Krell, R. D., 1987, In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist, J. Pharmacol. Exp. Ther. 243:548–556.
Snyder, D. W. and Krell, R. D., 1984, Pharmacological evidence for a distinct leukotriene C4 receptor in guinea-pig trachea, J. Pharmacol. Exp. Ther. 231:616–622.
Snyder, D. W. and Krell, R. D., 1986, Pharmacology of peptide leukotrienes on ferret isolated airway smooth muscle, Prostaglandins 32:189–200.
Sun, F. F., Chau, L. Y., Spur, B., Corey, E. J., Lewis, R. A. and Austen, K. F., 1986, Identification of a high affinity leukotriene C4-binding protein in rat liver cytosol as glutathione S-transferase, J. Biol. Chem. 261:8540–8546.
Tudhope, S. R., Cuthbert, N. J., Abram, T. S., Jennings, M. A., Maxey, R. J., Thompson, A. M., Norman, P. and Gardiner, P. J., 1994, BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes, Eur. J. Pharmacol. 264:317–323.
Wetmore, L. A., Gerard, N. P., Herron, D. K., Bollinger, N. G., Baker, S. R., Feldman, H. A. and Drazen, J. M., 1991, Leukotriene receptor on U-937 cells: discriminatory responses to leukotrienes C4 and D4, Am. J. Physiol. 261:L164–L171.
Viganò T., Accomazzo M. R., Hernandez A., Galbiati E., Aliev G., Nicosia S. and Folco G. C., 1995, Contraction and cytosolic calcium in human bronchial smooth muscle cells in culture, Pharm. Res. 31:358.
Yamaguchi, T., Kohrogi, H., Honda, I., Kawano O., Sugimoto, M., Araki, S. and Ando, M., 1992, A novel leukotriene antagonist, ONO-1078, inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro, Am. Rev. Respir. Dis. 146:923–929.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nicosia, S. et al. (1996). Receptors and Second Messengers for Cys-Leukotrienes. In: Folco, G.C., Samuelsson, B., Maclouf, J., Velo, G.P. (eds) Eicosanoids. NATO ASI Series, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0200-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0200-9_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0202-3
Online ISBN: 978-1-4899-0200-9
eBook Packages: Springer Book Archive